# Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

> **NCT02092558** · — · COMPLETED · sponsor: **Children's Hospital, Dziekanów Leśny, Poland** · enrollment: 2 (actual)

## Conditions studied

- The Follow-up Duration Was 1-8 Years.
- The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,
- Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,
- Night Wetting and Day Wetting, Menstruation's Disorders, Urolithiasis, Defects of Urinary
- System and Hematuria.

## Interventions

- **DRUG:** Second-generation cephalosporin, nitrofurantoin, 1% aminoglycoside solution
- **DRUG:** cephalosporin with chemotherapeutics

## Key facts

- **NCT ID:** NCT02092558
- **Lead sponsor:** Children's Hospital, Dziekanów Leśny, Poland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2009-01
- **Final completion:** 2013-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2014-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092558, "Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02092558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*